Medical oncology
GMC: 6053905
Dr Mark Tuthill is an experienced consultant medical oncologist and an expert in the use of immunotherapy in cancer treatment. Practicing at GenesisCare in Oxford, Dr Tuthill specialises in the treatment of early and recurrent cancer including breast cancer, prostate cancer, kidney cancer, and bladder cancer Treatment is personalised to each patient's needs and preferences and can include the use of chemotherapy, hormone therapy, immunotherapy, or cancer growth inhibitors.
Dr Tuthill originally qualified from University College London, and trained in Medical Oncology in London at the Royal Marsden, Hammersmith, Charing Cross, and the Chelsea and Westminster Hospitals. In 2015 he was appointed Consultant Medical Oncologist at Churchill Hospital, Oxford, where he acts as principal investigator on a number of clinical trials.
Dr Tuthill’s research interests include tumour immunology, cancer-growth inhibitors, and novel therapeutic drug combinations for the treatment of cancer. He is a principal investigator or sub-investigator for early and late phase clinical trials in tumour types including breast cancer, urological cancers and other tumour types. Dr Tuthill holds a PhD in Tumour Immunology from Imperial College London and regularly presents his research at national and international conferences. He is a clinical ambassador for UCARE (Urology Cancer Research and Education), an independent charity raising funds for research into prostate and bladder cancer, and is a member of The Association of Cancer Physicians.
A private messaging and video conference service that allows you to contact the best doctors at any time and place.
Start nowNutrition plays a vital role in supporting the body during cancer treatment, helping to maintain strength, manage side effects and improve overall well-being. Eating the right foods can aid recovery, support the immune system and help the body tolerate treatment more effectively.
Navigating the transition from early to advanced prostate cancer reveals a shift in treatment goals from cure to management. In his latest online article, Dr Mark Tuthill examines the factors driving prostate cancer progression, risk considerations, metastatic routes, and evolving prognosis dynamics. He explores the journey of prostate cancer, highlighting the challenges and strategies in its progression and management.
Leading consultant medical oncologist, and expert in the use of immunotherapy in cancer treatment, Dr Mark Tuthill discusses all you need to know about kidney cancer. He goes into expert detail about the early signs and symptoms, diagnosis of advanced kidney cancer and treatment for both early-stage and advanced versions of this condition.
Discover the latest developments in advanced bladder cancer treatments, including new drugs and personalised approaches. Explore how these advancements are changing the way we manage advanced stages of the condition and what it means for patients. In his latest online article, Dr Mark Tuthill navigates through the practical aspects of these breakthroughs and their potential impact on bladder cancer treatment.
Leading consultant medical oncologist Dr Mark Tuthill explains everything you need to know about advanced breast cancer, including the symptoms and diagnosis and provides tips on lifestyle changes which can help manage advanced breast cancer.
In the second article of a two-part series, leading consultant medical oncologist Dr Mark Tuthill discusses which breast cancer responds best to immunotherapy, and how the treatment differs from chemotherapy.
This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.